CINECA IRIS Institutional Research Information System

FERRANNINI, ELEUTERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.748
AS - Asia 22.916
EU - Europa 15.580
SA - Sud America 3.174
AF - Africa 529
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 19
Totale 86.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.383
SG - Singapore 6.800
CN - Cina 6.775
IT - Italia 4.891
HK - Hong Kong 3.764
BR - Brasile 2.683
SE - Svezia 2.319
BG - Bulgaria 1.707
VN - Vietnam 1.622
TR - Turchia 1.162
DE - Germania 1.148
UA - Ucraina 1.146
CA - Canada 1.096
KR - Corea 1.032
GB - Regno Unito 910
FI - Finlandia 899
RU - Federazione Russa 753
FR - Francia 747
CH - Svizzera 488
IN - India 388
BD - Bangladesh 244
JP - Giappone 221
IQ - Iraq 174
AR - Argentina 154
MX - Messico 123
PK - Pakistan 106
AT - Austria 101
SA - Arabia Saudita 94
BE - Belgio 83
CI - Costa d'Avorio 82
NL - Olanda 74
UZ - Uzbekistan 73
EC - Ecuador 72
ZA - Sudafrica 72
MA - Marocco 70
VE - Venezuela 67
CO - Colombia 64
ID - Indonesia 63
PL - Polonia 63
SN - Senegal 60
ES - Italia 57
KE - Kenya 53
AU - Australia 52
JO - Giordania 47
EG - Egitto 46
NP - Nepal 38
GR - Grecia 35
PY - Paraguay 34
IE - Irlanda 33
AE - Emirati Arabi Uniti 30
CL - Cile 30
IL - Israele 30
TN - Tunisia 30
PE - Perù 29
UY - Uruguay 29
JM - Giamaica 27
PH - Filippine 26
DZ - Algeria 24
BJ - Benin 22
MY - Malesia 22
OM - Oman 21
KZ - Kazakistan 20
ET - Etiopia 18
TT - Trinidad e Tobago 18
CZ - Repubblica Ceca 17
LB - Libano 16
RO - Romania 16
AL - Albania 15
AZ - Azerbaigian 15
BH - Bahrain 14
CR - Costa Rica 14
EU - Europa 14
LT - Lituania 14
PA - Panama 14
KW - Kuwait 13
NG - Nigeria 13
PS - Palestinian Territory 13
DO - Repubblica Dominicana 12
HU - Ungheria 12
NZ - Nuova Zelanda 12
TW - Taiwan 12
TH - Thailandia 11
BO - Bolivia 10
HN - Honduras 10
DK - Danimarca 9
MN - Mongolia 9
PT - Portogallo 9
GE - Georgia 8
KG - Kirghizistan 8
BS - Bahamas 7
GT - Guatemala 7
IR - Iran 7
RS - Serbia 7
AM - Armenia 6
BB - Barbados 6
BN - Brunei Darussalam 6
GA - Gabon 6
NI - Nicaragua 6
SV - El Salvador 6
AO - Angola 5
Totale 85.923
Salva come PNG Salva come JPEG
Città #
Fairfield 4.810
Ashburn 4.641
Singapore 3.900
Hong Kong 3.725
Woodbridge 3.443
Chandler 2.573
Ann Arbor 2.315
Houston 2.273
Milan 2.070
Seattle 1.940
San Jose 1.846
Sofia 1.703
Cambridge 1.592
Wilmington 1.591
Santa Clara 1.536
Jacksonville 1.516
Dallas 1.486
Hefei 1.292
Shanghai 1.244
Beijing 1.222
Seoul 1.008
Ottawa 956
New York 948
Izmir 756
Boardman 731
Serra 694
Princeton 687
Lawrence 636
Nanjing 617
Medford 607
Lauterbourg 540
Los Angeles 501
Bern 461
Des Moines 425
Ho Chi Minh City 319
Buffalo 296
Istanbul 282
Dearborn 264
Jüchen 257
Nanchang 253
Hanoi 251
San Diego 228
Dong Ket 222
São Paulo 220
Tokyo 195
Redondo Beach 177
Falls Church 170
The Dalles 168
Helsinki 166
Rome 163
Columbus 158
Munich 158
Kunming 151
Council Bluffs 144
Shenyang 129
London 125
Hebei 114
Boulder 113
Chicago 98
Tianjin 97
Frankfurt am Main 93
Redwood City 92
Changsha 91
Ogden 91
Jiaxing 83
Abidjan 82
Rio de Janeiro 79
Florence 78
Brussels 75
Norwalk 72
Pisa 71
Washington 71
Lancaster 69
Vienna 69
Dhaka 68
Baghdad 64
Tashkent 64
Belo Horizonte 62
Da Nang 62
Dakar 59
Pune 59
Hangzhou 58
Nuremberg 53
Brasília 49
Orange 49
Guangzhou 48
Curitiba 47
Haiphong 45
Warsaw 45
Nairobi 44
San Francisco 41
Zhengzhou 40
Auburn Hills 39
Jinan 38
Porto Alegre 38
Düsseldorf 36
Lahore 36
Verona 36
Amman 35
Chennai 35
Totale 63.569
Salva come PNG Salva come JPEG
Nome #
Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus 317
F-18-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: A validation study 269
[C-11]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia 258
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 246
Quantification of liver glucose metabolism by positron emission tomography: Validation study in pigs 246
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 239
EFFECT OF FATTY-ACIDS ON GLUCOSE-PRODUCTION AND UTILIZATION IN MAN 227
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 225
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects 225
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest 218
THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW 217
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. 217
SPLANCHNIC AMINO-ACID AND GLUCOSE-METABOLISM DURING AMINO-ACID INFUSION IN DOGS 214
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 212
RESPONSE TO INTRAVENOUS GLUCOSE OF PATIENTS ON MAINTENANCE HEMODIALYSIS - EFFECTS OF DIALYSIS 210
PATTERN OF INSULIN DELIVERY AFTER INTRAVENOUS GLUCOSE INJECTION IN MAN AND ITS RELATION TO PLASMA-GLUCOSE DISAPPEARANCE 210
INSULIN RESISTANCE, INSULIN DEFICIENCY AND THE PATHOGENESIS OF DIABETES-MELLITUS 210
LACK OF EFFECT OF PARATHYROID-HORMONE ON HEPATIC GLUCOSE-METABOLISM IN THE DOG 209
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 209
ADRENERGIC-BLOCKADE ALTERS GLUCOSE KINETICS DURING EXERCISE IN INSULIN-DEPENDENT DIABETICS 207
Skin Vasodilator Function and Vasomotion in Patients with Morbid Obesity: Effects of Gastric Bypass Surgery 207
PARENTAL HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK-FACTORS 206
Effect of 1-year treatment with interferon-beta 1b on thyroid function and autoimmunity in patients with multiple sclerosis 206
REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN 204
INSULIN ACTION AND SUBSTRATE COMPETITION 204
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 203
THE DISPOSAL OF AN ORAL GLUCOSE-LOAD IN HEALTHY-SUBJECTS - A QUANTITATIVE STUDY 201
ACUTE RESPIRATORY-DISTRESS SYNDROME IN AN ADULT PATIENT WITH A MYELODYSPLASTIC DISORDER 201
MECHANISM OF IMPROVEMENT IN GLUCOSE-METABOLISM AFTER CHRONIC GLYBURIDE THERAPY 201
SODIUM ELEVATES THE PLASMA-GLUCOSE RESPONSE TO GLUCOSE-INGESTION IN MAN 199
A MODEL OF GLUCOSE KINETICS AND THEIR CONTROL BY INSULIN, COMPARTMENTAL AND NONCOMPARTMENTAL APPROACHES 198
HEPATIC AND EXTRAHEPATIC SPLANCHNIC GLUCOSE-METABOLISM IN THE POSTABSORPTIVE AND GLUCOSE FED DOG 197
OPERATION OF RANDLES CYCLE IN PATIENTS WITH NIDDM 196
ACUTE ELEVATION OF FREE FATTY-ACID LEVELS LEADS TO HEPATIC INSULIN RESISTANCE IN OBESE SUBJECTS 196
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects 196
HEPATIC AND PERIPHERAL INSULIN RESISTANCE - A COMMON FEATURE OF TYPE-2 (NON-INSULIN-DEPENDENT) AND TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS 195
TRANSIENT HEPATIC RESPONSE TO GLUCAGON IN MAN - ROLE OF INSULIN AND HYPERGLYCEMIA 195
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 195
Adipocyte P2X(7) receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome? 195
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 195
DIFFERENTIAL-EFFECTS OF INSULIN AND HYPERGLYCEMIA ON INTRACELLULAR GLUCOSE DISPOSITION IN HUMANS 194
EFFECT OF INSULIN AND GLUCOSE ON FEEDING-BEHAVIOR 192
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery 192
IMPAIRED INSULIN DEGRADATION IN A PATIENT WITH INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS 191
Sibutramine lost and found 191
Physical activity and insulin sensitivity - the RISC Study 191
THE PATHOGENESIS OF NON-INSULIN-DEPENDENT DIABETES 190
Effects of insulin on the kidney and the cardiovascular system 189
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. 189
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance 187
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline 187
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 186
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. 186
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T-4 replacement therapy 185
INFLUENCE OF LONG-TERM DIABETES ON LIVER-GLYCOGEN METABOLISM IN THE RAT 183
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 182
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 182
Insulin: new roles for an ancient hormone 182
INTERNAL BILIARY DIVERSION IMPROVES GLUCOSE-TOLERANCE IN THE RAT 181
METABOLIC EFFECTS OF LOW-DOSE INSULIN THERAPY ON GLUCOSE-METABOLISM IN DIABETIC-KETOACIDOSIS 180
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects 180
RELATION OF BIRTH-WEIGHT TO MATERNAL PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS DURING NORMAL-PREGNANCY 179
Adiponectin and left ventricular structure and function in healthy adults 179
Differential effect of weight loss on insulin resistance in surgically treated obese patients 179
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis 178
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. 178
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 176
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 175
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 175
SYNERGISTIC INTERACTION BETWEEN EXERCISE AND INSULIN ON PERIPHERAL GLUCOSE-UPTAKE 174
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 174
Beta-cell function in obesity: effects of weight loss 174
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 174
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control 173
Hypertension, insulin resistance, and diabetes 172
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects 172
Long-term effects of bariatric surgery on meal disposal and beta-cell function in diabetic and nondiabetic patients. 172
POSTPERICARDIECTOMY SYNDROME IN A PATIENT WITH RADIATION-INDUCED PERICARDIAL-EFFUSION 171
INFLUENCE OF PLASMA-GLUCOSE AND INSULIN CONCENTRATION ON PLASMA-GLUCOSE CLEARANCE IN MAN 171
TIME-DEPENDENCE OF THE INTERACTION BETWEEN LIPID AND GLUCOSE IN HUMANS 171
METABOLIC BASIS OF OBESITY AND NONINSULIN-DEPENDENT DIABETES-MELLITUS 171
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation 171
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 171
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells 171
Fasting-based estimates of insulin sensitivity in overweight and obesity: A critical appraisal 170
INSULIN KINETICS AND GLUCOSE-INDUCED INSULIN DELIVERY IN CHRONICALLY DIALYZED SUBJECTS - ACUTE EFFECTS OF DIALYSIS 169
EFFECTS OF PHYSIOLOGICAL PLASMA-INSULIN LEVELS ON GLUCOSE-TURNOVER PARAMETERS IN FAMILIAL HYPERCHOLESTEROLEMIA 169
Effect of acute hyperglycemia on insulin secretion in humans 169
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism 169
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery 169
LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES 168
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. 168
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 168
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients 167
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 167
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 167
Quantification of D-mannose in plasma: Development and validation of a reliable and accurate HPLC-MS-MS method 167
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes 166
beta-cell function in morbidly obese subjects during free living - Long-term effects of weight loss 166
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 166
Totale 19.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 241.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 241.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.102 0 0 0 0 0 0 0 0 0 0 271 831
2021/20226.921 99 372 166 482 1.405 1.004 138 354 396 210 314 1.981
2022/20236.532 923 645 328 631 867 1.014 59 513 1.054 56 372 70
2023/20246.556 1.153 887 902 486 1.025 1.011 49 234 121 71 75 542
2024/202517.384 48 728 78 862 1.242 1.689 1.363 1.183 1.819 2.455 2.133 3.784
2025/202616.852 1.687 2.884 2.092 1.117 1.290 2.003 2.617 823 716 1.583 40 0
Totale 86.741